← Back to Search

Procedure

BEAR Device vs. Autograft for ACL Tear (BEAR-MOON Trial)

N/A
Recruiting
Led By Kurt P Spindler, MD
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Selected surgical treatment of ACL injury
18-55 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up kt-1000 instrumented knee laxity measure 2 years after surgery (difference from contralateral knee)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing BEAR, a new knee surgery method using a sponge to help a torn ligament heal. It targets patients aged 18-55 who need ACL surgery. The sponge helps the torn ligament ends grow back together naturally. BEAR has shown promising results in early studies, suggesting it may be a viable alternative to traditional ACL reconstruction methods.

Who is the study for?
This trial is for individuals aged 18-55 who have a complete ACL tear confirmed by MRI and are within 50 days of their injury. They must be considered candidates for ACL surgery, agree to follow study procedures including activity restrictions, and provide informed consent.
What is being tested?
The study compares two surgical techniques for repairing torn ACLs: the new BEAR method using a blood-enriched implant to promote healing, versus the traditional BPTB reconstruction that uses transplanted patellar tendon tissue.
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include pain at the surgery site, infection risk from surgery, knee stiffness or weakness during recovery. The BEAR method aims to reduce invasive surgery burden.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have chosen surgery for my ACL injury.
Select...
I am between 18 and 55 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~marx activity 2 years after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and marx activity 2 years after surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
IKDC (International Knee Documentation Committee) Score
KT-1000
Secondary study objectives
Active Knee Range of Motion
Knee
Hop Test Limb Difference
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bridge Enhanced ACL RestorationExperimental Treatment1 Intervention
Procedure/Surgery Bridge Enhanced ACL Restoration (BEAR): The surgical repair of the ACL using the BEAR technique involves surgically placing a sponge (the BEAR implant) between the torn ends of the ACL, providing a sponge for the ligament ends to group into.
Group II: ACL Reconstruction(BPTB Graft)Active Control1 Intervention
Procedure/Surgery ACL Reconstruction (Bone Patellar Tendon Bone Graft): Standard of care surgical procedure Patellar Tendon Autograft ACL reconstruction, in which a bone-patellar tendon-bone graft from the front of the knee is taken to replace the torn ACL.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The BEAR technique for treating ACL tears involves placing a blood-enriched sponge between the torn ends of the ACL to promote natural healing and reattachment, leveraging the body's own healing processes. This method is less invasive compared to the standard Bone-Patellar Tendon-Bone (BPTB) reconstruction, which replaces the torn ACL with a graft from the patient's patellar tendon, requiring additional surgery to harvest the graft. Understanding these mechanisms is important for patients as it highlights differences in surgical invasiveness, recovery times, and potential long-term outcomes, such as the risk of osteoarthritis.

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,057 Previous Clinical Trials
1,371,560 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
502 Previous Clinical Trials
1,089,818 Total Patients Enrolled
1 Trials studying Anterior Cruciate Ligament Tear
40 Patients Enrolled for Anterior Cruciate Ligament Tear
Miach OrthopaedicsIndustry Sponsor
4 Previous Clinical Trials
1,120 Total Patients Enrolled
2 Trials studying Anterior Cruciate Ligament Tear
120 Patients Enrolled for Anterior Cruciate Ligament Tear
Kurt P Spindler, MDPrincipal InvestigatorThe Cleveland Clinic
1 Previous Clinical Trials
300 Total Patients Enrolled

Media Library

ACL Reconstruction (Bone Patellar Tendon Bone Graft) (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03776162 — N/A
Anterior Cruciate Ligament Tear Research Study Groups: ACL Reconstruction(BPTB Graft), Bridge Enhanced ACL Restoration
Anterior Cruciate Ligament Tear Clinical Trial 2023: ACL Reconstruction (Bone Patellar Tendon Bone Graft) Highlights & Side Effects. Trial Name: NCT03776162 — N/A
ACL Reconstruction (Bone Patellar Tendon Bone Graft) (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03776162 — N/A
~82 spots leftby May 2027